Aspen Pharmacare is under investigation by the European Commission over its pricing practices for five cancer medicines. EU antitrust
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when
Cinfa Biotech announced trial results for a biosimilar of Amgen’s Neulasta, a multi-billion blockbuster to treat chemotherapy-induced neutropenia. Cinfa Biotech
A new study has shown that an ingestible gastric balloon could be used to help obese people lose weight without
Business placing products on the market in Spain must notify their products ahead of 1 June 2017 or risk enforcement
Almost half of UK citizens say they or someone they know have experienced delays in care due to problems
The German pharmaceuticals market is set to rise from $67.9 billion (€52.9 billion) in 2016 to around $86.3 billion
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of
Product design and development company Cambridge Consultants is exploring how augmented reality (AR) could potentially be used in surgery
Clinigen Group’s Idis Managed Access division and Tesaro have partnered to launch a Managed Access Program (also known as
Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable
The European Medicines Agency’s (EMA) 2016 annual report focuses on the Agency’s key achievements in the areas of medicine evaluation, support
An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is
The results from the asthma arm of the world’s first digitally enhanced Randomised Controlled Trial (RCT) have been announced.
According to a new study, the life expectancy of 20-year-olds starting HIV treatment has increased by a decade in the
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and
This year’s advisory board for CPhI Worldwide has been announced by organiser, UBM EMEA. Featuring five new global experts, the
Ashfield Healthcare Communications, a global healthcare communications agency, announces significant growth across the UK and Europe. Ashfield Healthcare Communications has
Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for
Advertisements
